Isochroman compounds for treatment of cns disorders
申请人:Agejas-Chicharro Javier
公开号:US20050014750A1
公开(公告)日:2005-01-20
This invention relates to compounds of formula (I) where R1 to R12, —W—V—, —X—Y—, p and n have the values defined in claim
1,
their preparation and use as pharmaceuticals.
Isochroman compounds for treatment of CNS disorders
申请人:Eli Lilly and Company
公开号:US07335660B2
公开(公告)日:2008-02-26
This invention relates to compounds of formula (I)
where R1 to R12, —W—V—, —X—Y—, p and n have the values defined in claim 1, their preparation and use as pharmaceuticals for the treatment of central nervous system disorders, such as depression, bipolar disorder, and anxiety.